本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Janux Therapeutics, Inc.

15.19
+0.15001.00%
盤後15.00-0.1900-1.25%19:44 EDT
成交量:62.37萬
成交額:942.34萬
市值:9.24億
市盈率:-8.28
高:15.24
開:15.00
低:14.90
收:15.04
52周最高:35.34
52周最低:12.12
股本:6,083.17萬
流通股本:4,168.06萬
量比:0.77
換手率:1.50%
股息:- -
股息率:- -
每股收益(TTM):-1.8336
每股收益(LYR):-1.8336
淨資產收益率:-11.48%
總資產收益率:-9.55%
市淨率:0.97
市盈率(LYR):-8.28

資料載入中...

2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/03/08

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/08

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/08

重要事件披露

Form 8-K - Current report
2024/03/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/04

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/29

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/01

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/16

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]